| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,425 |
5,950 |
$223K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,311 |
2,051 |
$96K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,412 |
2,030 |
$41K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,675 |
2,396 |
$31K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
2,577 |
1,015 |
$30K |
| 87807 |
|
1,219 |
1,104 |
$11K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,164 |
976 |
$11K |
| 90461 |
|
3,180 |
784 |
$6K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
706 |
668 |
$5K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
466 |
458 |
$5K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
126 |
126 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
21 |
20 |
$1K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
829 |
778 |
$652.90 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
17 |
13 |
$26.50 |
| 90677 |
|
310 |
304 |
$0.14 |
| 90619 |
|
12 |
12 |
$0.08 |
| 90697 |
|
103 |
102 |
$0.05 |
| 90670 |
|
166 |
142 |
$0.00 |
| 90633 |
|
39 |
39 |
$0.00 |
| 90710 |
|
53 |
53 |
$0.00 |
| 90715 |
|
12 |
12 |
$0.00 |
| 90648 |
|
25 |
15 |
$0.00 |
| 90680 |
|
251 |
238 |
$0.00 |
| 90698 |
|
12 |
12 |
$0.00 |
| 90656 |
|
14 |
14 |
$0.00 |